Patents
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
01/2006
01/25/2006EP1619183A2 1-amido-3-(2-hydroxyphenoxy)-2-propanol derivatives and a process for preparing 2-amidomethyl-1, 4-benzodioxane derivatives
01/25/2006EP1618091A1 Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists
01/25/2006EP1618084A1 Bioreductively activated stilbene prodrugs
01/25/2006EP1212318B1 Substituted indolinones as tyrosine kinase inhibitors
01/25/2006EP1097158B1 Ligands for metals and metal-catalyzed processes
01/25/2006EP0978392B1 Optical recording media
01/25/2006CN1726603A Charge transport compositions and electronic devices made with such compositions
01/25/2006CN1726217A Substituted pyrrolo-pyrazole derivatives as kinase inhibitors
01/25/2006CN1726201A Substituted piperazines,(1,4) diaszepines, and 2,5-diazabicyclo (2.2.1)iieptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists
01/25/2006CN1726191A Substituted indole oxo-acetyl amino acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1)
01/25/2006CN1726190A Substituted 3-carbonyl-1h-indol-1-yl acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1)
01/25/2006CN1726185A Formulations comprising selective androgen receptor modulators and using method thereof
01/25/2006CN1726029A Substituted dihydropyrano indole-3,4-dione derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1)
01/25/2006CN1724535A Production method of 9-nitro camptothecin
01/25/2006CN1724534A Metal aza porphyrin compound containing fluorene diaryl ethylene and its preparation method and application
01/25/2006CN1724528A Preparation methd of 2,2',3,4'-diphenyl thioether tetra acid dianhydride
01/25/2006CN1724520A Indenoindole ketone kind compound, its preparation method and use
01/25/2006CN1724519A Indole kind compound with insuline sensitizing activity and its preparation method and use
01/25/2006CN1724518A Preparation method of N-substituted imide
01/25/2006CN1238354C Analog of nerve growth factor (2S, 4S)-2-(2'substituent)-4-(indole-3-methine)-5,5-disubstituent group-1, 3-f azole alkane compound, preparation method and application thereof
01/25/2006CN1238323C Process for the solid phase synthesis of aldehydes, ketones, oximes, amines and hydroxamic acid compounds
01/24/2006US6989401 Sulfonic acid derivatives of hydroxamic acids and their use as medicinal products
01/24/2006US6989384 Antipicornaviral compounds and compositions, their pharmaceutical uses, and materials for their synthesis
01/24/2006CA2433366C Amlodipine free base
01/24/2006CA2352392C Eletriptan hydrobromide monohydrate
01/24/2006CA2171954C Method for the preparation of high purity substituted benz[e] indoles and the alkaline salts thereof
01/19/2006WO2006006573A1 Filter and cyanine compound
01/19/2006WO2006005955A1 Amide derivatives as inhibitors of histone deacetylase
01/19/2006WO2006005609A2 Substituted oxindol derivatives and medicaments containing the same
01/19/2006WO2005115981A3 A process for the preparation of 1-(9h-carbazol-4-yloxy)-3-2-(-methoxyphenoxy)-ethyl amino-propan-2-ol
01/19/2006WO2005105785A3 Indole derivatives for treatment of obesity
01/19/2006WO2005068422A3 Process for crystallization of ramipril and preparation of a hydrated form thereof
01/19/2006US20060014965 Indoline derivative and process for producing the same
01/19/2006US20060014964 Bicyclic and tricyclic amines as modulators of chemokine receptor activity
01/19/2006US20060014836 e.g. 1-(Benzofuran-2-carbonyl-3-(3-phenoxy-phenyl)-thiourea;viricides; hepatitis virus
01/19/2006US20060014819 Crystal of (2R,4R)-monatin potassium salt and sweetener composition containing same
01/19/2006US20060014818 and luteinizing hormone releasing hormone receptor antagonist; non-peptide; metabolic stability; oral bioavailability; 4-chlorobenzyl {1-[3-(1-carbamoyl-2-methylpropylcarbamoyl)-6,8-dichloro-2,3,4,9-tetrahydro-1H-carbazol-3-ylcarbamoyl]-2-methylpropyl}carbamate; neurodegeenerative diseases, HIV, AIDS
01/19/2006US20060014787 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
01/19/2006US20060014783 Sulfonylamino-acetic acid derivatives
01/19/2006US20060014752 Heterocyclic anti-epileptogenic agents and methods of use thereof
01/19/2006US20060014725 6-(1-benzyl-3-pentyl-1H-indol-2-yl)-1-bromo-2-naphthyl 1H-tetraazol-5-ylmethyl ether; useful in treating stroke associated with or resulting from atrial fibrillation; thrombolytic agents for prohylaxis of cardiovascular disorders
01/19/2006DE102004030753A1 3'-Alkoxy spirocyclische Tetram- und Tretronsäuren 3'-alkoxy spirocyclic tetramic and Tretronsäuren
01/19/2006CA2573380A1 Amide derivatives as inhibitors of histone deacetylase
01/19/2006CA2572469A1 Small molecule inhibition of a pdz-domain interaction
01/18/2006EP1616865A1 Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas
01/18/2006EP1616860A1 Crystalline form of (2R,4R)-Monatin potassium salt and sweetener composition containing same
01/18/2006EP1615915A1 Phenacyl 2-hydroxy-3-diaminoalkanes
01/18/2006EP1615904A2 Substituted benzosulphonamide as potentiators of glutamate receptors
01/18/2006EP1615888A1 Process for the preparation of carvedilol form-ii
01/18/2006EP1615887A1 Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists
01/18/2006EP1615886A1 [c]-fused bicyclic proline derivatives and their use for treating arthritic conditions
01/18/2006EP1615885A1 B -fused bicyclic proline derivatives and their use for treating arthritic conditions
01/18/2006EP1615636A1 Bicyclic compounds as nr2b receptor antagonists
01/18/2006EP1615634A1 Substituted azabicyclo hexane derivatives as muscarinic receptor antagonists
01/18/2006CN1723198A Aryl, aryloxy, and alkyloxy substituted 1h-indol-3-yl glyoxylic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1)
01/18/2006CN1723197A Substituted 3-alkyl and 3-arylalkyl 1h-indol-1-yl acetic acid derivatives as inhibitors of plasminogen activator inhibitor-1 (PAI-1)
01/18/2006CN1723022A inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 and type 2
01/18/2006CN1723020A Indole derivatives as beta-2 agonists
01/18/2006CN1721411A Benzimidazole derivatives as modulators IgE
01/18/2006CN1721405A Process for preparing 4-bromo-7-methyl indole-2-carboxylic acid
01/18/2006CN1721397A Omega-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
01/18/2006CN1237049C Preparation of 5-aminophthalimide
01/17/2006US6987188 3a,4,5,9b-tetrahydro-1H-benz[e]indol-2-yl amine-derived neuropeptideYreceptors ligands useful in the treatment of obesity and other disorders
01/17/2006US6987122 Antitumor agents; solid tumors of rectum, lungs
01/17/2006US6987113 3-hetero-arylideneazaindolin-2-one compounds
01/17/2006US6987092 Indigoid bisindole derivatives
01/17/2006CA2138930C Substituted benzenesulfonylureas and -thioureas, preparation processes and possible uses of pharmaceutical preparations based on these compounds
01/17/2006CA2118812C 5-ht4 receptor antagonists
01/12/2006WO2005094810A3 Novel pharmaceutical compositions
01/12/2006WO2004085539A3 Cyanine dye labelling reagents with meso-substitution
01/12/2006US20060009539 Maleimide-based radiation curable compositions
01/12/2006US20060009517 Tricyclic inhibitors of poly(ADP-ribose) polymerases
01/12/2006US20060009512 5-ht 1b/1d receptor agonists for the treatment of headache resulting from administering an endothelin receptor antagonist
01/12/2006US20060009511 N-(2-arylethyl) benzylamines as antagonists of the 5-ht6 receptor
01/12/2006US20060009510 Method of synthesizing indolinone compounds
01/12/2006US20060009462 Prodrugs of CC-1065 analogs
01/12/2006US20060009449 Naphthaline derivatives as H3 inverse agonists
01/12/2006CA2572058A1 Azaindoles useful as inhibitors of protein kinases
01/12/2006CA2571822A1 Preventive or therapeutic agent for vascular intimal proliferative disease
01/11/2006EP1614683A1 Indazole compounds and pharmaceutical compositions for inhibiting protein kinases, and methods for their use
01/11/2006EP1614680A2 Process for preparing 2-iminopyrrolidine derivatives
01/11/2006EP1614678A2 Sulfur substituted sulfonylaminocarboxylic acid N-heteroarylamides, their preparation, their use and pharmaceutical preparations comprising them
01/11/2006EP1614676A1 Compound inhibiting in vivo phosphorus transport and medicine containing the same
01/11/2006EP1613634A1 Indole acetamides as inhibitors of the hepatitis c virus ns5b polymerase
01/11/2006EP1613631A1 Pyrrolo 1,2-b pyridazine compounds and their uses
01/11/2006EP1613307A2 M sb 3 /sb muscarinic acetylcholine receptor antagonists
01/11/2006EP1491206A4 Induction method for cell differentiation
01/11/2006EP1104297B1 Compositions for the treatment of chronic lymphocytic leukemia
01/11/2006CN1720332A Substrates for O6-alkylguanine-DNA alkyltransferase
01/11/2006CN1720245A Oxime ester photoinitiators with heteroaromatic groups
01/11/2006CN1720227A N-arylsulfonyl-3-aminoalkoxyindoles
01/11/2006CN1720226A Methods of using and compositions comprising selective cytokine inhibitory drugs for the treatment and management of myeloproliferative diseases
01/11/2006CN1720225A N-arylsulfonyl-3-substituted indoles having serotonin receptor affinity, process for their preparation and pharmaceutical composition containing them
01/11/2006CN1720224A Vasculostatic agents and methods of use thereof
01/11/2006CN1718577A Medicinal composition containing alkyl acyl ramosqiong and its application
01/11/2006CN1235925C Solid phase synthesing method of aldehyde, ketonic, oxime, amine and isohydroximic acid compound
01/10/2006US6984735 Reacting a dihalaromatic compound with sulfoxide
01/10/2006US6984657 Indole derivatives as MCP-1 receptor antagonists
01/10/2006US6984637 Cyclic amine derivatives-CCR-3 receptor antagonists
01/10/2006US6984462 Organic electroluminescent devices using double-spiro organic compounds